Sundaram Preethi

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 28% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sundaram Preethi's trades of Catalyst Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
334.14
Quantity 60,399
Value US$1,363,280
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-12 2025-06-11
S Sale
55,768 +43.1%
209.21
US$1,783,356 		55,768 +43.1% 209.21 US$1,783,356
2025-06-11 2025-06-11
PrS Proposed sale
60,399
334.14
US$1,363,280 		60,399 334.14 US$1,363,280
2025-06-12 2025-06-10
S Sale
46,479 +28.3%
86.59
US$2,040,591 		46,479 +28.3% 86.59 US$2,040,591
2025-06-10 2025-06-10
PrS Proposed sale
2,324
26.41
US$61,383 		2,324 26.41 US$61,383
2022-11-15 2022-11-11
S Sale
28,393 -100.0%
16.50
US$468,484 		28,393 -100.0% 16.50 US$468,484
2022-11-15 2022-11-11
S Sale
28,393 -50.0%
16.25
US$461,386 		28,393 -50.0% 16.25 US$461,386
2022-09-16 2022-09-15
S Sale
18,214 -100.0%
14.49
US$263,921 		18,214 -100.0% 14.49 US$263,921